Results 201 to 210 of about 649,583 (215)

Antigen spreading mediates heterogeneous solid tumor eradication by DNA demethylating agent-programmed CAR T cells. [PDF]

Sci Adv
Guo Y, Tong C, Wei J, Wu Z, Lu Y, Han F, Zhang Y, Wang C, Shi J, Shi F, Wang Y, Han W.   +11 more
europepmc   +1 more source

Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation. [PDF]

Int J Nanomedicine
Wang R, Zhang Z, Du J, Chen J, Teng Y, Wang Q, Wu Z, Yang T, Jiang H.   +8 more
europepmc   +1 more source

Efficacy of PD-1/PD-L1 and LAG-3 immune checkpoint inhibitors in the treatment of patients with solid tumor. [PDF]

Front Immunol
Hu D, Duan J, Xie P, Li J, Zhao L, Chen B, Lu R, Tang H, Zheng X, Qu L.   +9 more
europepmc   +1 more source

Polymer Nanoparticle-Based Photodynamic Therapy Combined with Immunotherapy for Solid Tumor Treatment. [PDF]

Curr Issues Mol Biol
Lao J, Ye Q, Fan S, Cheng Z, Wu P.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Heather Parsons, Atish D. Choudhury, Michael L Cheng   +2 more
exaly  

Current and future cancer staging after neoadjuvant treatment for solid tumors

Ca-A Cancer Journal for Clinicians, 2021
James Brierley, Daniel C Sullivan, David R Byrd   +2 more
exaly  

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L. Siegel, Jill S. Barnholtz-Sloan, Carol Kruchko   +2 more
exaly  

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi, Javier Cortes, Jean-Charles Soria   +2 more
exaly  

Metastasis-directed radiation therapy may improve progression-free survival in patients with oligometastatic solid tumors

Ca-A Cancer Journal for Clinicians
Carrie Printz
exaly